Mistletoe Therapy
Mistletoe therapy is a well-established component of integrative oncology within the framework of Biological Medicine. Extracts of Viscum album are used to support immune regulation and systemic balance in patients with oncological conditions.
At BioMed Center Sonnenberg, standardized mistletoe preparations are applied under medical supervision as part of an individualized treatment strategy. The therapy is integrated into a comprehensive medical concept tailored to the patient’s clinical situation.
Medical and Immunological Perspective
From a biological medical perspective, oncological conditions are understood as systemic processes involving immune regulation, inflammatory balance, and metabolic stability. Mistletoe therapy is used to support regulatory mechanisms within this broader context.
The preparation is typically administered subcutaneously in individually adjusted dosages. Mild local skin reactions or a temporary increase in body temperature may occur and are interpreted as physiological responses to immune stimulation.
Treatment protocols are individually defined based on clinical assessment and may be continued under medical supervision beyond the inpatient stay.
“Mistletoe therapy supports immune regulation within integrative oncology.”
Therapeutic Focus
Mistletoe therapy is primarily used in integrative oncology. It may accompany conventional treatments such as chemotherapy or radiation therapy and can be integrated into post-treatment care plans.
Its role is supportive and complementary, forming part of a broader individualized medical concept.
Indications and Contraindications
Mistletoe therapy may be considered in patients with solid tumors or hematological malignancies as part of an integrative oncology approach. Indication is determined individually based on medical history, current treatment status, and overall clinical condition.
The therapy is not initiated during acute febrile infections or active inflammatory exacerbations of autoimmune disorders. It is contraindicated in cases of known hypersensitivity to mistletoe preparations. Careful medical evaluation is required in patients with pronounced allergic tendencies or uncontrolled respiratory conditions.
Your Next Steps
During your consultation, your medical history, current treatment plan, and overall clinical situation are carefully reviewed. Together, we assess whether mistletoe therapy can be integrated into your individualized treatment concept within an integrative oncology framework.
FAQs
Mistletoe therapy uses extracts of Viscum album to support immune regulation in integrative oncology. It is administered under medical supervision as a complementary treatment.
It is typically administered as a subcutaneous injection two to three times per week. The dosage is individually adjusted. In selected cases, intravenous application may be considered in a clinical setting.
Mild local skin reactions or a temporary increase in body temperature may occur. These effects are generally interpreted as signs of immune activation and are monitored by the medical team.
No. Mistletoe therapy is used as a complementary approach and does not replace conventional oncological treatment. Any treatment decisions must be made in coordination with the treating oncologist.
Duration depends on diagnosis, therapeutic goals, and individual response. Therapy may begin during an inpatient stay and continue as a medically supervised home treatment.
In selected cases, biological treatment concepts may also be suitable for children and adolescents. Diagnostic procedures and therapeutic strategies are always carefully adapted to age, developmental stage, and individual health status. Any treatment is carried out under strict medical supervision and in close consultation with parents or legal guardians.
Contact
BioMed Center Sonnenberg AG
Sonnenberg 16
9103 Schwellbrunn AR
Switzerland
+41 71 353 36 36
guest@biomed-sonnenberg.com